Broadening the debate over HIV and hormonal contraception

The Lancet Infectious Diseases

Volumn 15, Issue 2, 2015, Pages 135-136

  Colvin, Christopher J ^a   Harrison, Abigail ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT;

CONTRACEPTIVE BEHAVIOR; FAMILY PLANNING; HEALTH HAZARD; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); FEMALE; HIV INFECTIONS;

CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; MEDROXYPROGESTERONE ACETATE;

EID: 84921032683     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)71076-X     Document Type: Note

References (15)

1. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991, 163:233-239.
2. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007, 21:1771-1777.
3. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007, 21:85-95.
4. Kleinschmidt I, Rees H, Delany S, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007, 75:461-467.
5. Westhoff CL, Winikoff B DMPA and HIV: do we need a trial?. Contraception 2014, 90:353.
6. Polis CB, Curtis KM Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis 2013, 13:797-808.
7. Polis CB, Phillips SJ, Curtis KM, et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception 2014, 90:360-390.
8. Ralph LJ, McCoy SI, Shiu K, Padian NS Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis 2015, published online Jan 9. http://dx.doi.org/10.1016/S1473-3099(14)71052-7.
9. McConnell J Editor's note. Lancet Infect Dis 2014, 14:182.
10. Rees H, Consortium E DMPA and HIV: why we need a trial. Contraception 2014, 90:354-356.
11. Cates W Research on hormonal contraception and HIV. Lancet 2014, 383:303-304. on behalf of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Consortium.
12. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 2012, 26:F13-F19.
13. Jones HE Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions. Contraception 2014, 90:357-359.
14. Gollub EL, Stein Z Research on hormonal contraception and HIV. Lancet 2014, 383:304-305.
15. Petticrew M 'More research needed': plugging gaps in the evidence base on health inequalities. Eur J Public Health 2007, 17:411-413.